Matthew Davids, MD, MMSc

@DrMDavids

Hematologist/oncologist, CLL researcher, director of #lymphoma clinical research @DanaFarber, faculty @harvardmed. Tweets are my own & not medical advice.

Boston, USA davidslab.dana-farber.org Joined November 2014

364 Following 3.8K Followers 476 Posts

Latest posts 5

Matthew Davids, MD, MMSc @DrMDavids Jan 7, 2025

Thanks for having me on the podcast @chadinabhan, it was a lot of fun! @DanaFarber @PanMass @CllSociety

chadi nabhan MD, MBA, FACP Verified account @chadinabhan Jan 7, 2025

UR first 2025 #HealthcareUnfiltered podcast is W @DrMDavids of @DanaFarber sharing the FASCINATING story of venetoclax development & behind the scenes of how everything started; we also chat about new CLL data from #ASH24. Clip below & link.
A must listen

podcasts.apple.com/us/podcast/hea…

View quoted post on X

Matthew Davids, MD, MMSc @DrMDavids Dec 16, 2024

Please add this great @VJHemOnc event to your Jan calendar now so you don't miss it: Post-ASH 2024 CLL highlights webinar us06web.zoom.us/webinar/regist…

Matthew Davids, MD, MMSc @DrMDavids Dec 12, 2024

Matthew S. Davids on Triplet Therapy of Acalabrutinib Venetoclax and Obinutuzumab Focus on TP53 Aberrant CLL - The ASCO Post ascopost.com/videos/2024-as…

ascopost.com Matthew S. Davids, MD, MMSc, on Triplet Therapy of Acalabrutinib, Venetoclax, and Obinutuzumab:...

Matthew Davids, MD, MMSc @DrMDavids Dec 8, 2024

Happy to share our new paper from ⁦⁦@DanaFarber⁩ on AVO for 1L CLL with high-risk genetics just published in ⁦@JCO_ASCO⁩ ascopubs.org/doi/10.1200/JC…

ascopubs.org Phase II Study of Acalabrutinib, Venetoclax, and Obinutuzumab in a Treatment-Naïve Chronic Lympho... PURPOSEThe AMPLIFY trial recently established fixed-duration acalabrutinib, venetoclax, and obinutuzumab (AVO) as a new standard-of-care option for patients with previously untreated chronic lympho...

Matthew Davids, MD, MMSc @DrMDavids Oct 19, 2024

I highly encourage applying for this position in this dynamic group with an incredible PI/mentor @DanaFarber

Anthony Letai MD PhD @DrTonyLetai Oct 18, 2024

The Letai Lab at Dana-Farber and Harvard Medical School is hiring a cancer cell biology post-doc. Check it out, and please circulate! careers.dana-farber.org/job/10476/post…
View quoted post on X